Prevail Partners

BriaCell Therapeutics is an immuno-oncology biotechnology company based in West Vancouver, Canada, focused on developing innovative treatments for cancer. Its lead product, Bria-IMT, is a targeted cell-based immunotherapy currently undergoing Phase I/IIa clinical trials in combination with immune checkpoint inhibitors for the treatment of breast cancer. The company is also advancing Bria-OTS, a personalized off-the-shelf immunotherapy designed for advanced breast cancer, under a cooperative research agreement with the National Cancer Institute. Additionally, BriaCell is developing BriaDx, a diagnostic test to enhance treatment strategies. The company's mission centers on harnessing the body's immune system to combat cancer, aiming to provide safer and more effective alternatives to traditional chemotherapy.

PolyPhotonix is a bio-photonic research and development company focused on the design, development, and manufacture of non-invasive photonic-based medical devices. The company specializes in creating innovative home care treatment products that utilize light therapy to address macular eye diseases, particularly diabetic retinopathy. By collaborating with designers and key customers, PolyPhotonix supports the entire design process up to manufacturing at the National Printable Electronics Centre, aiming to pioneer the early adoption of organic light technology in medical applications.